Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
BROADVISION INC (BVSN)
|
Add to portfolio |
|
|
|
| Price: |
$4.35
| | Metrics |
| OS: |
5.06
|
M
| |
-20
|
% ROE
|
| Market cap: |
$22
|
M
| |
-172
|
% ROIC
|
|
Net cash:
|
$1.5
|
M
| |
$0.30
|
per share
|
|
EV:
|
$20.5
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($6.1)
|
M
| |
|
|
|
EBIT
|
($6.1)
|
M
| |
|
|
| EPS |
($0.45)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
| Revenues | 5.1 | 6.4 | 7.9 | 9.4 | 13.6 | 15.6 | 15.1 | 17.6 |
| Revenue growth | -20.5% | -19.9% | -15.9% | -30.5% | -12.9% | 3.1% | -13.8% | -19.5% |
| Cost of goods sold | 2.0 | 3.1 | 3.5 | 3.6 | 4.7 | 5.0 | 5.1 | 6.0 |
| Gross profit | 3.1 | 3.2 | 4.4 | 5.8 | 8.9 | 10.6 | 10.0 | 11.5 |
| Gross margin | 61.2% | 50.5% | 56.0% | 61.4% | 65.4% | 67.8% | 66.0% | 65.7% |
| Sales and marketing | 1.8 | 3.7 | 4.1 | 4.9 | 5.2 | 5.6 | 5.9 | 5.9 |
| Research and development | 5.0 | 6.6 | 6.9 | 7.2 | 7.3 | 7.1 | 6.4 | 6.4 |
| General and administrative | 3.1 | 3.7 | 3.6 | 3.5 | 3.9 | 3.9 | 4.0 | 4.0 |
| EBIT | -6.8 | -10.8 | -10.0 | -9.7 | -7.4 | -5.8 | -6.2 | -4.7 |
| EBIT margin | -135.5% | -169.3% | -125.4% | -102.3% | -54.4% | -37.0% | -40.7% | -27.0% |
| Pre-tax income | -7.0 | -10.0 | -9.4 | -11.4 | -9.3 | -5.3 | -4.9 | -5.3 |
| Income taxes | 0.0 | -0.1 | 0.0 | 0.0 | 0.2 | 0.1 | 0.1 | 0.1 |
| Tax rate | 0.4% | 1.1% | | | | | | |
| Net income | -7.0 | -9.9 | -9.5 | -11.4 | -9.5 | -5.4 | -5.1 | -5.4 |
| Net margin | -138.6% | -155.7% | -119.5% | -121.1% | -69.8% | -34.8% | -33.4% | -30.7% |
| |
| Diluted EPS | ($1.40) | ($1.99) | ($1.93) | ($2.35) | ($1.98) | ($1.15) | ($1.09) | ($1.20) |
| Shares outstanding (diluted) | 5.0 | 5.0 | 4.9 | 4.9 | 4.8 | 4.7 | 4.6 | 4.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|